PL352750A1 - Novel isoindoloindolone compounds, method of obtaining them and pharamcological composition containing such compounds - Google Patents

Novel isoindoloindolone compounds, method of obtaining them and pharamcological composition containing such compounds

Info

Publication number
PL352750A1
PL352750A1 PL02352750A PL35275002A PL352750A1 PL 352750 A1 PL352750 A1 PL 352750A1 PL 02352750 A PL02352750 A PL 02352750A PL 35275002 A PL35275002 A PL 35275002A PL 352750 A1 PL352750 A1 PL 352750A1
Authority
PL
Poland
Prior art keywords
compounds
isoindoloindolone
pharamcological
novel
obtaining
Prior art date
Application number
PL02352750A
Other languages
English (en)
Inventor
Michel Wierzbicki
Marie-Francoise Boussard
Anne Rousseau
Jean-Albert Boutin
Philippe Delagrange
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL352750A1 publication Critical patent/PL352750A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL02352750A 2001-03-12 2002-03-12 Novel isoindoloindolone compounds, method of obtaining them and pharamcological composition containing such compounds PL352750A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0103293A FR2821843B1 (fr) 2001-03-12 2001-03-12 Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PL352750A1 true PL352750A1 (en) 2002-09-23

Family

ID=8860976

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02352750A PL352750A1 (en) 2001-03-12 2002-03-12 Novel isoindoloindolone compounds, method of obtaining them and pharamcological composition containing such compounds

Country Status (24)

Country Link
US (1) US6465660B1 (cg-RX-API-DMAC7.html)
EP (1) EP1241169B1 (cg-RX-API-DMAC7.html)
JP (1) JP3842151B2 (cg-RX-API-DMAC7.html)
KR (1) KR100450313B1 (cg-RX-API-DMAC7.html)
CN (1) CN1159316C (cg-RX-API-DMAC7.html)
AR (1) AR034583A1 (cg-RX-API-DMAC7.html)
AT (1) ATE248171T1 (cg-RX-API-DMAC7.html)
AU (1) AU779702B2 (cg-RX-API-DMAC7.html)
BR (1) BR0200721A (cg-RX-API-DMAC7.html)
CA (1) CA2376876C (cg-RX-API-DMAC7.html)
DE (1) DE60200023T2 (cg-RX-API-DMAC7.html)
DK (1) DK1241169T3 (cg-RX-API-DMAC7.html)
EA (1) EA004035B1 (cg-RX-API-DMAC7.html)
ES (1) ES2206438T3 (cg-RX-API-DMAC7.html)
FR (1) FR2821843B1 (cg-RX-API-DMAC7.html)
HK (1) HK1049000B (cg-RX-API-DMAC7.html)
HU (1) HUP0200913A3 (cg-RX-API-DMAC7.html)
MX (1) MXPA02002601A (cg-RX-API-DMAC7.html)
NO (1) NO20021198L (cg-RX-API-DMAC7.html)
NZ (1) NZ517742A (cg-RX-API-DMAC7.html)
PL (1) PL352750A1 (cg-RX-API-DMAC7.html)
PT (1) PT1241169E (cg-RX-API-DMAC7.html)
SI (1) SI1241169T1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200202030B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826009B1 (fr) * 2001-06-13 2003-08-15 Servier Lab Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE60309324T2 (de) * 2002-06-21 2007-05-10 Suven Life Sciences Ltd. Tetracyclische arylcarbonyl indole mit serotoninrezeptoraffinität als arzneimittel, verfahren zu ihrer herstellung und pharmazeutische zubereitungen
CN1662538A (zh) * 2002-06-21 2005-08-31 苏文生命科学有限公司 可作为治疗剂的对血清素受体具有亲和力的芳烷基吲哚、其制备工艺及其含有该物质的药物组合物
KR100776118B1 (ko) * 2002-11-28 2007-11-15 수벤 라이프 사이언시스 리미티드 엔-아릴술포닐-3-아미노알콕시인돌
EA009367B1 (ru) * 2002-12-18 2007-12-28 Сувен Лайф Сайенсиз Лимитед ПРОИЗВОДНЫЕ 5-ТИА-5-ДИОКСО-4b-АЗАИНДЕНО[2,1-a]ИНДЕНА, ОБЛАДАЮЩИЕ АФФИННОСТЬЮ К РЕЦЕПТОРУ СЕРОТОНИНА
RU2387655C2 (ru) * 2004-08-09 2010-04-27 Бристол-Маерс Сквибб Компани Ингибиторы репликации вируса гепатита с
ES2580702B1 (es) 2015-02-25 2017-06-08 Palobiofarma, S.L. Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina
US20240090802A1 (en) 2022-09-02 2024-03-21 Dexcom, Inc. Continuous analyte sensor devices and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377098A (en) * 1976-12-16 1978-07-08 Sumitomo Chem Co Ltd Preparation of indoloisoquinoline derivative
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US5441955A (en) * 1993-11-19 1995-08-15 Pathogenesis Corporation Indolo[2,1-biquinazoline-6,12-dione antibacterial compounds and methods of use thereof
FR2743365A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa Derives de 5h,10h-imidazo(1,2-a)indolo(3,2-e)pyrazine-4-one, leur preparation et les medicaments les contenant
AU2001268677A1 (en) * 2000-06-23 2002-01-08 Cognetix, Inc. Subtype selective melatonergics

Also Published As

Publication number Publication date
EP1241169B1 (fr) 2003-08-27
HUP0200913A2 (hu) 2002-11-28
CA2376876C (fr) 2006-07-11
CN1375494A (zh) 2002-10-23
KR100450313B1 (ko) 2004-09-30
FR2821843B1 (fr) 2003-05-09
CA2376876A1 (fr) 2002-09-12
JP3842151B2 (ja) 2006-11-08
AU2324202A (en) 2002-09-19
EP1241169A1 (fr) 2002-09-18
CN1159316C (zh) 2004-07-28
HK1049000B (zh) 2005-01-07
AU779702B2 (en) 2005-02-10
PT1241169E (pt) 2003-11-28
JP2002265469A (ja) 2002-09-18
NO20021198L (no) 2002-09-13
AR034583A1 (es) 2004-03-03
ZA200202030B (en) 2002-10-03
HUP0200913A3 (en) 2004-11-29
DE60200023D1 (de) 2003-10-02
DE60200023T2 (de) 2004-06-03
HK1049000A1 (en) 2003-04-25
HU0200913D0 (cg-RX-API-DMAC7.html) 2002-05-29
FR2821843A1 (fr) 2002-09-13
ATE248171T1 (de) 2003-09-15
US6465660B1 (en) 2002-10-15
NO20021198D0 (no) 2002-03-11
KR20020072782A (ko) 2002-09-18
EA200200241A1 (ru) 2002-10-31
ES2206438T3 (es) 2004-05-16
BR0200721A (pt) 2002-12-03
SI1241169T1 (en) 2003-12-31
NZ517742A (en) 2003-02-28
EA004035B1 (ru) 2003-12-25
MXPA02002601A (es) 2004-11-12
DK1241169T3 (da) 2003-11-24

Similar Documents

Publication Publication Date Title
PL353910A1 (en) Novel compounds 0 derivatives of alpha-amino acid, method of obtaining them and compositions containing such derivatives
HRP20040665B1 (en) Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
EG23078A (en) Metal containing composition and process therewith
IL156949A0 (en) Method of synthesizing camptothecin-relating compounds
GB0128287D0 (en) Novel method and compounds
PL341549A1 (en) Novel-beta-carbolinic compounds, method of obtaining them and pharmacological compositions containing such compounds
PL355161A1 (en) Method of manufacture
PL369600A1 (en) Methods and compositions of novel triazine compounds
PL355126A1 (en) Novel method of obtaining compounds containing at least one or more amide bonds
PL345236A1 (en) Novel benzenesulphonamide compounds, method of obtaining them and pharmacological compositions containing such compounds
PL352750A1 (en) Novel isoindoloindolone compounds, method of obtaining them and pharamcological composition containing such compounds
GB2396914B (en) Method of mass spectrometry
PL354948A1 (en) Novel benzenesulphonamide compounds, method of obtaining them and pharmacological compositions containing such compounds
PL352866A1 (en) Novel isoindoloindolone compounds, method of obtaining tehm and pharmacological compoistion containing such compounds
IL158004A0 (en) Method of enhancing entomophilous
PL355066A1 (en) Novel n-benzylpiperazine compounds, method of obtaining them and pharmacological compositions containing such compounds
PL353511A1 (en) Novel compounds of pyrimidin-4-one, method of obtaining them and pharmacological compositions containing such compounds
PL347056A1 (en) Novel compounds of heterocycloalkylbezocyclobutane and heterocycloarylbenzocyclobutane, method of obtaining them and pharmacological compositions containming such compounds
PL345916A1 (en) Novel compounds of 6-amino- or 6-hydrazin-sulphonyl-3-quinolinylphosphonic acid, method of obtaining them and pharmacological compositions containing such compounds
PL351732A1 (en) Novel compounds of cycloheptene, method of obtaining them and pharmacological compositions containing such compounds
PL347046A1 (en) Cyclobutaindole-carboxamide compounds, methods of obtaining them and pharmacological compositions containing such compounds
PL354565A1 (en) Novel cyclic alpha-amino-gamma-hydroxyamide compounds, method of obtaining them and pharmacological compositions containing such compounds
GB0107033D0 (en) Method and composition
PL345918A1 (en) Novel compounds of 6-sulphamoyl-3-quinolinylphosphonic acid, method of obtaining them and pharmacological compositions containing such compounds
GB2389227B (en) Method of mass spectrometry

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)